✦ LIBER ✦

B cell tolerance induced by polymeric antigens. VI. Kinetics and reversibility of the inhibition of antibody-forming cells by antigen

✍ Scribed by G. G. B. Klaus

Publisher: John Wiley and Sons
Year: 1976
Tongue: English
Weight: 687 KB
Volume: 6
Category: Article
ISSN: 0014-2980
DOI: 10.1002/eji.1830060603

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

B cell tolerance induced by polymeric an

B cell tolerance induced by polymeric antigens IV. Antigen-mediated inhibition of antibody-forming cells

✍ G. G. B. Klaus 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 813 KB

## Abstract The role of antibody‐forming cell (AFC) blockade in the genesis of hapten‐specific tolerance induced by hapten (2,4‐dinitrophenyl)‐coupled pneumococcal polysaccharide (DNP‐lys‐S3) was investigated. Tolerizing doses of DNP‐lys‐S3 given to mice making antibodies to DNP‐hemocyanin a day be

B cell tolerance induced by polymeric an

B cell tolerance induced by polymeric antigens. III. Dissociation of antibody formation and memory generation in tolerant mice

✍ G. G. B. Klaus; H. N. A. Willcox 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 755 KB

B cell tolerance induced by polymeric an

B cell tolerance induced by polymeric antigens V. Different avidities of primed and virgin precursor cells for paucivalent antigen

✍ H. N. A. Willcox; G. G. B. Klaus 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 412 KB

B cell tolerance induced by polymeric an

B cell tolerance induced by polymeric antigens. II. Effects of tolerance on hapten-binding lymphocyte levels in primary and secondaryantibody responses

✍ G. G. B. Klaus 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 667 KB

B cell tolerance induced by polymeric an

B cell tolerance induced by polymeric antigens. I. Comparison of thedose and epitope density requirement for inactivation of primed and unprimed B cells in vivo

✍ G. G. B. Klaus; J. H. Humphrey 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 502 KB

Anti-CD3-based bispecific antibody desig

Anti-CD3-based bispecific antibody designed for therapy of human B-cell malignancy can induce T-cell activation by antigen-dependent and antigen-independent mechanisms

✍ Brian K. Link; Sheri A. Kostelny; Michael S. Cole; William P. Fusselman; J. Yun 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 107 KB 👁 2 views

## Anti -CD3 ؋ anti-B-cell antigen bispecific monoclonal antibodies (bsAbs) can redirect T-cell-mediated lysis toward malignant B cells. Clinical trials with CD3-based bsAbs have shown toxicity in patients which is likely related to nonspecific T-cell activation and targeting. Our current studies